ORIGINAL RESEARCH article

Front. Microbiol., 10 December 2021

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 12 - 2021 | https://doi.org/10.3389/fmicb.2021.547020

Plasmid Mediated mcr-1.1 Colistin-Resistance in Clinical Extraintestinal Escherichia coli Strains Isolated in Poland

  • 1. Department of Microbiological Diagnostics and Infectious Immunology, Medical University of Białystok, Białystok, Poland

  • 2. Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, United Kingdom

  • 3. Department of Microbiology, Institute of Biology, University of Białystok, Białystok, Poland

  • 4. Regional Centre for Transfusion Medicine, Białystok, Poland

  • 5. Second Department of Nephrology and Hypertension with Dialysis Unit, Medical University of Białystok, Białystok, Poland

  • 6. Second Department of General and Gastroenterological Surgery, Medical University of Białystok, Białystok, Poland

  • 7. Department of Neurology, Medical University of Białystok, Białystok, Poland

  • 8. Department of Vascular Surgery and Transplantation, Medical University of Białystok, Białystok, Poland

  • 9. Department of Clinical Molecular Biology, Medical University of Białystok, Białystok, Poland

  • 10. Department of Anesthesiology and Intensive Care, Medical University of Białystok, Białystok, Poland

  • 11. Department of Hematology, Medical University of Białystok, Białystok, Poland

Abstract

Objectives: The growing incidence of multidrug-resistant (MDR) bacteria is an inexorable and fatal challenge in modern medicine. Colistin is a cationic polypeptide considered a “last-resort” antimicrobial for treating infections caused by MDR Gram-negative bacterial pathogens. Plasmid-borne mcr colistin resistance emerged recently, and could potentially lead to essentially untreatable infections, particularly in hospital and veterinary (livestock farming) settings. In this study, we sought to establish the molecular basis of colistin-resistance in six extraintestinal Escherichia coli strains.

Methods: Molecular investigation of colistin-resistance was performed in six extraintestinal E. coli strains isolated from patients hospitalized in Medical University Hospital, Bialystok, Poland. Complete structures of bacterial chromosomes and plasmids were recovered with use of both short- and long-read sequencing technologies and Unicycler hybrid assembly. Moreover, an electrotransformation assay was performed in order to confirm IncX4 plasmid influence on colistin-resistance phenotype in clinical E. coli strains.

Results: Here we report on the emergence of six mcr-1.1-producing extraintestinal E. coli isolates with a number of virulence factors. Mobile pEtN transferase-encoding gene, mcr-1.1, has been proved to be encoded within a type IV secretion system (T4SS)-containing 33.3 kbp IncX4 plasmid pMUB-MCR, next to the PAP2-like membrane-associated lipid phosphatase gene.

Conclusion: IncX4 mcr-containing plasmids are reported as increasingly disseminated among E. coli isolates, making it an “epidemic” plasmid, responsible for (i) dissemination of colistin-resistance determinants between different E. coli clones, and (ii) circulation between environmental, industrial, and clinical settings. Great effort needs to be taken to avoid further dissemination of plasmid-mediated colistin resistance among clinically relevant Gram-negative bacterial pathogens.

Introduction

The growing incidence of multidrug-resistant (MDR) bacteria is an unavoidable challenge in modern medicine. Constant selection of MDR bacteria significantly contributes to the reduction of available therapeutic options. Colistin, also referred to as polymyxin E, is a cationic polypeptide considered a “last-resort” antimicrobial for treating infections caused by MDR Gram-negative bacterial pathogens, along with carbapenems and tigecycline (). Colistin was originally introduced in the 1950s for the treatment of infections caused by Gram-negative bacteria; however, polymyxins fell out of favor in the middle of the 1970s due to high rates of nephro- and neurotoxicity coupled with the advent of less toxic antibacterial agents. Nevertheless, by the mid-1990s (), polymyxins were reintroduced into clinical practice due to the emergence of extensively drug-resistant (XDR) Gram-negative bacteria, and currently serve a critical role in the antimicrobial armamentarium (). Moreover, colistin often stands as the last antimicrobial agent retaining activity against carbapenem-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii (Olaitan et al., 2014). Unfortunately, bacterial resistance to polymyxin E emerged rapidly, and could potentially lead to essentially untreatable infections, particularly in the hospital setting where aforementioned XDR microorganisms frequently cause life-threatening infections in the most vulnerable patient populations ().

Colistin is capable of interacting with lipid A moiety of the lipopolysaccharide (LPS), thereby expelling Ca2+ and Mg2+ ions from phosphate groups and resulting in disruption of the negatively charged outer membrane (OM) of Gram-negative bacteria. Therefore, the ability of bacteria to resist killing by antimicrobial cationic polypeptides often entails modification of the OM (LPS modification resulting in reduced OM net negative charge). Polymyxin resistance has increased gradually within the last few years, and knowledge on a wide variety of possible chromosomal or acquired resistance mechanisms is still expanding (Olaitan et al., 2014). Most mechanisms conferring polymyxin resistance are directed at modifications of the lipid A moiety of the LPS, which is the primary target of colistin. Most genetic alterations, either chromosomal or acquired, entail a common lipid A modification pathway with 4-amino-4-deoxy-L-arabinose (L-Ara4N) and/or phosphoethanolamine (pEtN) addition. The most important target of L-Ara4N is the 4′-phosphate group of lipid A, but it can also be added to the 1-phosphate group or 3-deoxy-D-manno-oct-2-ulosonic acid (Kdo) (). Substitution of the phosphate groups by L-Ara4N is followed by significant reduction of net negative charge of lipid A to 0, while pEtN modifications are associated with a net charge decrease from −1,5 to −1 (). Therefore, L-Ara4N modification seems to be the most effective, owing to the nature of the OM charge modification (Olaitan et al., 2014). In Enterobacteriaceae, the aforementioned modifications of lipid A can result from mutation in the two-component systems (TCSs) such as PhoPQ, BasSR (PmrAB), small feedback-inhibition peptide MgrB, as well as from plasmid-mediated determinants (i.e., mcr gene encoding pEtN transferase) (Zeng et al., 2016; ; Roer et al., 2017; Torpdahl et al., 2017; Osei Sekyere, 2019). The first plasmid-mediated polymyxin resistance gene, termed as mcr-1 (currently mcr-1.1) was identified in China in November 2015, and was subsequently reported all over the world, in both retrospective and prospective studies (). The earliest, so far described, mcr-producing strains date back to the end of the previous century, in the 1980s (Shen et al., 2016). The earliest mcr-producing bacterial strain of clinical origin was a Shigella sonnei isolated from a pediatric patient in Vietnam, in 2008 (Pham Thanh et al., 2016). The various mcr variants (mcr-1 to mcr-10) have been so far, identified in various species of Gram-negative pathogens originating from animals, meat, food products, environmental, and human sources (Partridge et al., 2018; ). The emergence of plasmid-mediated pEtN transferase-encoding genes is a matter of serious concern due to the potential for rapid dissemination via horizontal gene transfer. Broad distribution of mcr genes in multidrug-resistant hospital strains would be especially dangerous in clinical settings, and could possibly result in wide dissemination of pandrug-resistant bacteria and untreatable infections. Here, we report on the emergence of mcr-1.1-harboring IncX4 plasmid in six extraintestinal Escherichia coli strains of clinical origin isolated in University Hospital of Bialystok, Poland between 2016 and 2018.

Materials and Methods

Clinical Isolates Used in the Study

Colistin-resistant E. coli isolates were obtained during microbiological screening of infected patients hospitalized in Medical University Hospital in Bialystok, between 2016 and 2018. Extraintestinal solates originated from postoperative wound swab, bedsore swab, perianal abscess swab, pharyngeal swab, bronchial aspirate, and endotracheal tube secretion. Clinical characteristics of the patients colonized by extraintestinal mcr-1.1-producing E. coli strains are presented in Table 1.

TABLE 1

Patient 1
M6
ST-553
–:H20		Second Clinic of Nephrology
Clinical origin: bedsore swab
Date of isolation: 6th September 2017
Diagnosis: end-stage renal disease (lupus nephropathy)
Antimicrobial therapy: ceftazidime, ciprofloxacin;
Hospitalization: Clinic of General and Gastroenterological Surgery, ICU
Patient 2
M9
ST-6856
O176:H45		2nd Clinical Department of General and Gastroenterological Surgery
Clinical origin: perianal abscess swab
Date of isolation: 5th March 2018
Diagnosis: perianal abscess
Antimicrobial therapy: cephazolin, ciprofloxacin, metronizadole;
Hospitalization: 1st Clinical Department of General and Endocrine Surgery
Patient 3
M10
ST-162
O126:H45		Department of Hematology
Clinical origin: pharyngeal swab
Date of isolation: 13th March 2018
Diagnosis: philadelphia chromosome-positive chronic myeloid leukemia
Antimicrobial therapy: colistin, amikacin, gentamicyn, meropenem, ciprofloxacin, piperacillin with tazobactam, metronidazole, linezolid, vancomycin.
Hospitalization: Clinic of Internal and Metabolic Diseases;
Patient 4
M11
ST-10
O89m:H9		Department of Neurology
Clinical origin: bronchial aspirate
Date of isolation: 29th March 2018
Diagnosis: ischemic stroke; hypertension; type-II diabetes; heart failure;
Antimicrobial therapy: amoxicillin with clavulanic acid;
Hospitalization: none
Patient 5
M12
ST-10
O89m:H10		Department of Vascular Surgery and Transplantation
Clinical origin: postoperative wound swab
Date of isolation: 4th May 2018
Diagnosis: critical ischemia of the left lower limb due to atherosclerosis;
Antimicrobial therapy: metronidazole, linezolid.
Hospitalization: Vascular Surgery, ICU
Patient 6
M14
ST-93
O7:H4		2nd Clinical Department of General and Gastroenterological Surgery
Clinical origin: endotracheal tube secretion
Date of isolation: 21st July 2016
Diagnosis: entrapment of the femoral hernia; hypertension; ischemic heart disease;
Antimicrobial therapy: tetracycline, ciprofloxacin, metronizadole;
Hospitalization: none

Clinical characteristics of the patients colonized by extraintestinal mcr-1.1-producing E. coli strains.

Bacterial Identification and Antimicrobial Susceptibility Testing

Bacterial isolates identification was performed with VITEK-MS (bioMérieux, Marcy l’Etoile, France); with subsequent antimicrobial susceptibility testing (AST) using the VITEK 2 system (bioMérieux, Marcy l’Etoile, France), SensiTest Colistin broth microdilution method (Liofilchem, Roseto degli Abruzzi, Italy), and MIC Test Strips (Liofilchem, Roseto degli Abruzzi, Italy) following manufacturer guidelines. AST results were interpreted in accordance with European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria.

Whole Bacterial DNA Extraction and Sequencing

Whole bacterial DNA from six clinical extraintestinal E. coli was isolated from Luria Broth overnight cultures with use of silica column-based Genomic Mini AX Bacteria kit (A&A Biotechnology). Purified bacterial DNA was sequenced using both short- and long-read methodologies (Illumina and Oxford Nanopore Technology).

In the first step of molecular analysis, Nextera XT library preparation kit and Nextera XT Indexes (Illumina) were used for previously quantified bacterial DNA, which was simultaneously fragmented and tagged with sequencing adapters in a single-tube enzymatic reaction. Quality and quantity of libraries were assessed by fluorometry (Qubit, Thermo Fisher Scientific) and chip electrophoresis (2100 Bioanalyzer, Agilent). FASTQ reads were generated with the use of MiSeq Reagent Kit v3 (600 cycles) and MiSeq analyzer (Illumina).

In the next step, DNA libraries were prepared with the use of a Ligation Sequencing Kit (SQK-LSK109) with Native Barcoding Expansion (EXP-NBD104). Quality and quantity of libraries were assessed by fluorometry (Qubit, Thermo Fisher Scientific) and chip electrophoresis (2100 Bioanalyzer, Agilent). FASTQ reads were generated with the use of Spot-ON Flow Cell (FLO-MIN106D R9 Version) and MinION Mk1b analyzer (Oxford Nanopore Technology).

Raw Data Quality Assessment and Downstream Bioinformatics

After quality assessment and quality filtering, reads were trimmed (Trimmomatic in case of Illumina reads), and demultiplexed with Porechop in case of long ONT reads (). Full structures of bacterial chromosomes and plasmids were recovered using Unicycler hybrid assembler which utilizes spades.py, racon, makeblastdb, tblastn, bowtie2, samtools, bcftools, and pilon (Wick et al., 2017). Alignment and mapping of nucleotide sequences were performed using Geneious 10.0.9 software (Biomatters Ltd., Auckland, New Zealand). A RAST (Rapid Annotation using Subsystem Technology)-annotated genomes were subjected to subsequent in silico analyses with use of PlasmidFinder, Resfinder, Virulence Finder (; ; ).

Strain Phylogenomics

The final assembled genome sequence data were uploaded to the Type (Strain) Genome Server (TYGS), a free bioinformatics platform available under https://tygs.dsmz.de, for a whole genome-based taxonomic analysis ().

For the phylogenomic inference, all pairwise comparisons among the set of genomes were conducted using the Genome BLAST Distance Phylogeny approach (GBDP) and accurate intergenomic distances inferred under the algorithm ‘trimming’ and distance formula d5 (). Phylogenomic tree inferred with FastME 2.1.6.1 () from GBDP distances calculated from genome sequences.

IncX4 Plasmids Phylogenomics

For the purpose of IncX4 plasmid phylogenomic inference, 100 similar sequences from the BLAST database were aligned and analyzed with the use of Clustal Omega (clustalo 1.2.4). Resulting phylogenetic tree was visualized using iTOL v61 (). Structural comparison between colistin-conferring plasmids harbored by studied extraintestinal E. coli isolates and IncX4 plasmid sequences deposited in NCBI was prepared using BLAST Ring Image Generator (BRIG) – default parameters with 90/70 as upper/lower threshold ().

Transconjugation Assays

Electrotransformation of the IncX4 plasmid into the recipient E. coli strain was performed in order to confirm its influence on colistin-resistance phenotype in clinical E. coli isolates. To determine whether mcr-1.1 gene was located on pMUB-MCR 33.3 kbp IncX4 plasmid, transconjugation experiments were performed, with plasmid profiles preparation using Plasmid Mini AX kit (A&A Biotechnology), and subsequent electrotransformation into plasmid-free and colistin-sensitive E. coli TOP10 strain. Electrotransformation with subsequent selection of the transformants on the Luria-Bertani medium containing 1 mg/L colistin was conducted for the E. coli TOP10 strain.

Results

Extraintestinal E. coli isolates incorporated into the described study presented a relatively similar antimicrobial resistance pattern (66.66%; 4 of 6). E. coli MIN6 ST-553, MIN10 ST-162, MIN11 ST-10, and MIN12 ST-10 were found to be resistant to amoxicillin/clavulanic acid (MIC > 32 mg/L), ciprofloxacin (MIC ≥ 4 mg/L), trimethoprim/sulfamethoxazole (MIC ≥ 320 mg/L), and colistin (MIC = 4 mg/L, except of strain MIN12 – MIC = 8 mg/L). E. coli MIN9 ST-6856 was found to be resistant to amoxicillin/clavulanic acid (MIC > 32 mg/L), gentamicin (MIC ≥ 16 mg/L), ciprofloxacin (MIC ≥ 4 mg/L), trimethoprim/sulfamethoxazole (MIC ≥ 320 mg/L), and colistin (MIC = 4 mg/L). Furthermore, E. coli MIN14 strain was resistant to amoxicillin/clavulanic acid (MIC > 32 mg/L), and presented the highest colistin MIC = 16 mg/L. Detailed antimicrobial susceptibility testing results of six extraintestinal E. coli strains are presented in Table 2.

TABLE 2

M6
ST-553
–:H9		M9
ST-6856
O176:H45		M10
ST-162
O126:H45		M11
ST-10
O89:H9		M12
ST-10
O89:H10		M14
ST-93
O7:H4
Amikacin≤2S≤2S≤2S≤2S≤2S≤2S
Gentamicin≤1S≥16R≤1S≤1S≤1S≤1S
Amoxicillin/Clavulanic acid≥32R≥32R16R≥32R≥32R≥32R
Cefepime≤0.12S≤0.12S≤0.12S≤0.12S≤0.12S≤0.12S
Cefotaxime≤0.25S≤0.25S≤0.25S−−≤0.25S≤0.25S
Cefuroxime4S−−4S−−8S4S
Imipenem≤0.25S≤0.25S≤0.25S≤0.25S≤0.25S≤0.25S
Meropenem≤0.25S≤0.25S≤0.25S≤0.25S≤0.25S≤0.25S
Ciprofloxacin≥4R≥4R≥4R≥4R≥4R≤0.25S
Tigecycline≤0.5S≤0.5S−−−−−−≤0.5S
Trimethoprim/Sulfamethoxazole≥320R≥320R≥320R≥320R≥320R≤20S
Colistin4R4R4R4R8R16R

Antimicrobial susceptibility of extraintestinal mcr-1.1-producing E. coli strains.

Whole-genome sequencing with use of a hybrid assembly approach allowed us to recover full genome and mobilome structures of tested extraintestinal colistin-resistant E. coli strains. Detailed characteristics of the sequenced genomes are presented in Table 3.

TABLE 3

StrainAccession no./GenBank sequenceSTO:H genotypeCoverage (X)Size (Mb)No. of contigsNo. of plasmids%GCNo. of rRNAsNo. of tRNAsN50L50No. of coding sequencesNo. of CRISPR arraysChromosomal MGEChromosomal antimicrobial resistance determinants
MIN6SAMN17831481
CP069692.1		533−:H202455.1879850.9122864,989,84515177244mdf(A); gyrA:p.S83L; parC:p.S80I; gyrA:p.D87N; parC:p.E84G
MIN9SAMN17831482
CP069682.1		6856O176:H45805.03210950.5522864,590,31515045228mdf(A); gyrA:p.D87N; gyrA:p.S83L; parC:p.S80I
MIN10SAMN17831483
CP069677.1		162O126:H452605.4025450.5622975,122,97315389239mdf(A);
gyrA:p.S83L; gyrA:p.D87N;
MIN11SAMN17831484
CP069666.1		10O89m:H9964.988111050.4122874,768,30614930239mdf(A); blaTEM–1A;
aadA1; dfrA1;
parC:p.S80R; gyrA:p.S83L; gyrA:p.D87N; parE:p.E460D;
MIN12SAMN17831485
CP069657.1		10O89m:H104845.2749850.7922874,896,56815302148mdf(A); tet(B); gyrA:p.D87N; parC:p.S80I; gyrA:p.S83L; parE:p.S458A
MIN14SAMN17831486
CP069646.1		93O7:H4835.032111050.6222904,780,47515029128mdf(A);

Detailed characteristics of the sequenced E. coli genomes.

Moreover, all six colistin-resistant extraintestinal E. coli strains were equipped with a relatively rich plasmidic panel (Table 4). Interestingly, all of the tested strains harbored a IncX4 33.3 kbp plasmid pMUB-MCR, with the mobile pEtN transferase-encoding gene, mcr-1.1, which has been proved to be encoded within a type IV secretion system (T4SS), next to the PAP2-like membrane-associated lipid phosphatase gene (Figures 1, 2). The biological consequences of pMUB-MCR IncX4 plasmid possession were evaluated with the use of a transconjugation assay. The E. coli TOP10 electrotransformants carrying the 33.3 kbp IncX4 plasmid showed a MIC of colistin of 2 mg/L, which corresponded to a 16-fold increase as compared to the recipient E. coli TOP10 strain. These data confirmed that 33.3 kbp IncX4 pMUB-MCR conjugative plasmid is responsible for colistin-resistance in six extraintestinal clinical E. coli strains isolated from patients hospitalized in Medical University Hospital in Bialystok, Poland. Moreover, phylogenomics of IncX4 plasmids bearing mobile pEtN transferase-encoding genes is presented in Figure 3.

TABLE 4

StrainPlasmid nameLength (bp)%GCPlasmid typeMobile genetic elements
(position in contig)		Content
MIN6pMUB-MIN6-MCR33 28841.84IncX4IS26(20481–21300)mcr-1.1; virB1; virB3; virB5; virB6; virB8; virB9; virB10; virB11; cag12 pathogenicity island; hemolysin expression modulator; hicAB toxin/antitoxin;
pMUB-MIN6-189 95651.50IncFIIcn_3430_IS26 with blaTEM–1B(12228–15658); IS26(14839–15658); Tn4352(10370–13046); ISSso4(60189–62827); IS421(51366–52697); cn_9380_IS26(14838–24218)blaTEM–1B; aph(3″)-Ib; aadA1; aph(6)-Id; tet(B); dfrA1; sul2; mercuric resistance; lutA; lutC;
pMUB-MIN6-256 89748.08IncX1−blaTEM–1B; mercuric resistance; aadA1; dfrA15; sul1; hemolysin expression modulator;
pMUB-MIN6-3629343.83−−DNA adenine methylase; RNAI modulator protein Rom;
pMUB-MIN6-4563147.38−−mobilization protein MobC, mobilization protein MbeD; RNAI modulator protein Rom; mRNA interferase RelE; RelE/StbE;
pMUB-MIN6-5208043.37−−chaperone protein DnaJ;
pMUB-MIN6-6155151.52Col(MG828)−repA – replication protein-encoding gene
pMUB-MIN6-7150650.02Col(MG828)−repA – replication protein-encoding gene
MIN9pMUB-MIN9-MCR33 30341.85IncX4IS26(860–1679)mcr-1.1; virB1; virB3; virB5; virB6; virB8; virB9; virB10; virB11; cag12 pathogenicity island; hemolysin expression modulator; hicAB toxin/antitoxin;
pMUB-MIN9-1283 24547.11IncHI2ATn6024(97840–130262); ISKpn12(172884–173725)blaTEM–1A; sul1; sul2; sul3; tet(A); dfrA1; aadA1; aac(3″)-IIa; aadA2b; aph(3″)-Ib; aph(6)- Id; catA1; cmlA1;
pMUB-MIN9-2102 70347.67p0111IS26(98806–99625); IS421(17495–18833); IS30(32630–33851); IS903(37021–38077);cobalt-zinc-cadmium resistance; AidA-I adhesin-like protein; tet(A);
pMUB-MIN9-3579246.65Col440l−mobilization protein MobC, mobilization protein mbeD; RNAI modulator protein Rom; mRNA interferase RelE; RelE/StbE;
pMUB-MIN9-4530951.12−−aph(3′)-I; RNAI modulator protein Rom; TnpA transposase; mobilization protein MobC
pMUB-MIN9-5401853.33−−mobilization protein MobC
pMUB-MIN9-6337155.15−−mobilization protein MobC; RNAI modulator protein Rom; mobilization protein MbeD
pMUB-MIN9-7319147.82−−psp operon transcriptional activator; qnrB19;
pMUB-MIN9-8155251.87Col(MG828)−repA – replication protein-encoding gene
MIN10pMUB-MIN10-MCR33 30541.84IncX4IS26(20365–21184)mcr-1.1; virB1; virB3; virB5; virB6; virB8; virB9; virB10; virB11; cag12 pathogenicity island; hemolysin expression modulator; hicAB toxin/antitoxin;
pMUB-MIN10-1146 90850.44IncFIC(FII)cn_31050_ISVsa5 with blaTEM–1B(46166–77216); IS26(60077–60896); ISEc17(22077–23334); IS26(76249–77068); ISVsa5(115219–116547); ISVsa5(46167–47495); IS629(7713–9008); cn_16992_IS26(60076–77068); cn_16992_IS26(60076–77068); cn_23129_ISVsa5(24366–47495);blaTEM–1B; adA1; sul3; dfrA1; tet(A); macA; macB; siderophore iroN; mercuric resistance operon; aerobactin
pMUB-MIN10-298 08447.86p0111−pgmP; recT; Phd-Doc toxin/antitoxin; parAB; pmgL
pMUB-MIN10-3155251.87Col(MG828)−repA – replication protein-encoding gene
MIN11pMUB-MIN11-MCR33 30341.85IncX4IS268688–9507mcr-1.1; virB1; virB3; virB5; virB6; virB8; virB9; virB10; virB11; cag12 pathogenicity island; hemolysin expression modulator; hicAB toxin/antitoxin;
pMUB-MIN11-185 44050.2IncFIIIS26(53084–53903); ISEc31(83647–84904); IS26(30158–30977); IS629(7713–9022); ISEc32(70540–71719); cn_1081_IS26(52822–53903); cn_2984_IS26(53083–56067); cn_7228_IS26(30157–37385);VapB-VapC toxin/antitoxin; PemL-PemK toxin/antitoxin; tetR; tet(A); permease of the drug/metabolite transporter (DMT) superfamily; RepFIB replication protein A; transcription activator mig-14; outer membrane protease OmpT; InsO; stability (stb) locus of IncFII plasmid NR1; colicin-M; microcin-M; resolvase; yuaX; arsenical resistance operon repressor; integron integrase IntI1; ant(3″)-Ia; phosphoserine phosphatase; ant(3″)-Ia; cmlA1 (MFS efflux pump); ant(3′)-I; mercuric resistance operon regulatory protein MerR; sitABCD (hydrogen peroxide resistance)
pMUB-MIN11-274 91249.7IncFII(pCoo)−Phd-Doc toxin/antitoxin; plasmid SOS inhibition proteins PsiA and PsiB; repA2; tetR; tet(B); traM; traY; traJ; traA; traB; traP; traU; traQ; traG; traS; traX; traK; traV; traR; trbA; trbE; trbI; trbC; trbB; trbJ; traW; traF; traH; traT; traD; yihA; finO; traL traC; traI;
pMUB-MIN11-3587447.53−−mobilization protein MobC; RNAI modulator protein Rom; Permease of the drug/metabolite transporter (DMT) superfamily
pMUB-MIN11-4551445.96−−mRNA interferase RelE;RelB/StbD replicon stabilization protein (antitoxin to RelE/StbE)
pMUB-MIN11-5543347.01−−mobilization protein MobC; RNAI modulator protein Rom
pMUB-MIN11-6428642.23Col440I−DNA-cytosine methyltransferase
pMUB-MIN11-7208947.2Col(BS512)−replication protein;
pMUB-MIN11-8155251.87Col(MG828)−repA – replication protein-encoding gene
pMUB-MIN11-9150650.27Col(MG828)−repA – replication protein-encoding gene
MIN12pMUB-MIN12-MCR33 30341.85IncX4IS26(8688–9507)mcr-1.1; virB1; virB3; virB5; virB6; virB8; virB9; virB10; virB11; cag12 pathogenicity island; hemolysin expression modulator; hicAB toxin/antitoxin;
pMUB-MIN12-1163 42750.62IncFIITn4352(55106–57785); Tn4352(72038–74717); Tn4352(69216–71895); Tn4352(66394–69073); Tn4352(63572–66251); Tn4352(60750–63429); Tn4352(57928–60607); IS26(74860–75679); IS26(84711–85530); IS26(30158–30977); IS26(77059–77878); ISEc31(161634–162891); IS629(7713–9022); ISEc32(144647–145826); IS102(127162–128218); cn_2957_IS26(30157–33114); cn_1782_IS26(73897–75679); cn_2199_IS26(74859–77058); cn_1159_IS26(76719–77878); cn_8472_IS26(77058–85530);blaTEM–1B; repFIB; ompT; colicin M; microcin M; vapB; arsenic resistance operon; dfrA; aph(6)-Id; aph(3″)-Ia; cmlA; aph(3)-I; tetA; tetR; pemKI; traA; traB; traC; traD; traE; traF; traG; traH; traI; traJ; traK; traL; traP; traR; traS; traT; traQ; traU; traV; traW; traX; traY; trbA; trbB; trbC; trbD; trbE; trbG; trbI; trbJ; trbN;
pMUB-MIN12-295 52653.35IncB/O/K/ZTn2(36309–41258); ISVsa3(31313–32289);blaTEM–1B; Phd-Doc toxin/antitoxin; psiAB; virD2; floR; aph(6)-Id; aph(3)-I; pilM; pilV; pilS; pilQ; traB; traU; traW; traS;
pMUB-MIN12-361 25751.49IncFII(pCoo)−Phd-Doc toxin/antitoxin; plasmid SOS inhibition proteins PsiA and PsiB; repA2; finO; tet(B); tetR; traM; traY; traA; traL; traE; trbD; traR; traC; traW; trbC; traN; trbE; trbA; trbB; traH; traD; traK; traP; trbG; traV; trbI; traU; trbC; traQ; trbJ; traH; traS; traT; traB; traU; traN; traF; trbB; traH; traG; traI; traX;
pMUB-MIN12-412 69660.37−−resolvase;
pMUB-MIN12-5587447.53−−mobilization protein MobC; RNAI modulator protein Rom; permease of the drug/metabolite transporter (DMT) superfamily; mobilization protein MbeD
pMUB-MIN12-6389751.78Col156−repA – replication protein-encoding gene; mobilization protein;
pMUB-MIN12-7225542.75Col(MG828)−ORF8;
MIN14pMUB-MIN14-MCR33 29041.85IncX4IS26(6158–6975)mcr-1.1; virB1; virB3; virB5; virB6; virB8; virB9; virB10; virB11; cag12 pathogenicity island; hemolysin expression modulator; hicAB toxin/antitoxin;
pMUB-MIN14-189 67448.07−−Phd-Doc toxin/antitoxin; RelE/StbE toxin/antitoxin; phage DNA binding protein Roi; phage baseplate hub; gp7; gp6; DNA recombination-dependent growth factor RdgC; Chromosome partitioning protein ParA; ATP-dependent Clp protease ATP-binding subunit ClpX; pmgC; pmgB; lydB; phage tail fiber protein (long tail fiber); phage serine/threonine protein phosphatase NinI; heat shock protein C; replication initiation protein RepE;
pMUB-MIN14-267 97451.42IncFII(pCoo)Tn801 with blaTEM–1D(2133–7081);blaTEM–1D; Phd-Doc toxin/antitoxin; plasmid SOS inhibition proteins PsiA and PsiB; repA2; stable plasmid inheritance protein B; tet(B); tetR; X polypeptide; traM; traJ; traY; traA; traL; traE; traK; traB; traP; trdB; trbG; traV; traR; traC; trbI; traW; traU; trbC; traN; trbE; traF; trbA; traQ; trbB; trbJ; traH; traG; traS; traT; traD; traI; traX; finO;
pMUB-MIN14-345 89350.70IncNTn2 with blaTEM–1B(9973–14916); ISKpn19(4298–7148);blaTEM–1B; replication initiation protein RepE; RND efflux system, inner membrane transporter; phage DNA invertase; resolvase/integrase Bin; phage integrase, site-specific serine recombinase; IncN plasmid KikA protein; T4SS – virB; virB3; virB5; virB8; virB10; virB11; antirestriction protein ArdA; error-prone repair protein UmuD; error-prone, lesion bypass DNA polymerase V (UmuC)
pMUB-MIN14-4409149.57Col8282−plasmid replication initiation protein
pMUB-MIN14-5368851.41−−mobilization protein MobC; RNAI modulator protein Rom; mobilization protein MbeD
pMUB-MIN14-6255344.42Col440I−9.4 kDa protein
pMUB-MIN14-7156551.05Col(MG828)−repA – replication protein-encoding gene
pMUB-MIN14-8155251.87Col(MG828)−repA – replication protein-encoding gene
pMUB-MIN14-9150750.23Col(MG828)−repA – replication protein-encoding gene

Plasmids harbored by six extraintestinal colistin-resistant E. coli strains.

FIGURE 1

FIGURE 2

FIGURE 3

In addition to the IncX4 33.3 kbp plasmid pMUB-MCR, the tested E. coli strains were equipped with relatively rich plasmid panels. E. coli MIN6 possessed seven plasmids, two of which constituted a vehicle for antimicrobial resistance determinants, namely pMUB-MIN6-1 (IncFII plasmid), and pMUB-MIN-6-2 (IncX1 plasmid). E. coli MIN9 harbored eight plasmids, four of which constituted a vehicle for antimicrobial resistance determinants, namely pMUB-MIN9-1 (IncHI2A), pMUB-MIN9-2 (p0111), pMUB-MIN9-4, and pMUB-MIN9-7. E. coli MIN10 possessed three plasmids, one of which constituted a vehicle for antimicrobial resistance determinants, namely pMUB-MIN10-1 – IncFIC(FII). Among nine plasmids harbored by E. coli MIN11, two were responsible for antimicrobial resistance determinants carriage, namely pMUB-MIN-11-1 (IncFII), and pMUB-MIN-11-2 [IncFII(pCoo)]. E. coli MIN12 harbored seven plasmids, three of which possessed antimicrobial resistance determinants, namely pMUB-MIN12-1 (IncFII), pMUB-MIN12-2 (IncB/O/K/Z), and pMUB-MIN12-3 [IncFII(pCoo)]. Furthermore, among nine plasmids possessed by E. coli MIN14, two harbored antimicrobial resistance genes, namely pMUB-MIN14-2 [IncFII(pCoo)], and pMUB-MIN14-3 (IncN). Detailed features of plasmids harbored by studied E. coli strains are presented in Table 4.

The MLST approach was utilized in order to evaluate the molecular relatedness of tested extraintestinal colistin-resistant E. coli strains. Among 6 tested clinical strains, two were proven to be clonally related, namely E. coli MIN11 and MIN12, which belonged to ST-10. Those two strains were isolated within an interval of 36 days, in the Department of Neurology (MIN11) and Department of Vascular Surgery and Transplantation (MIN12). However, those two strains were easily distinguished by O:H genotype (MIN11 – O89m:H9 vs., MIN12 – O89m:H10), plasmid content (MIN11 – 10 plasmids vs. MIN12 – 8 plasmids), number of chromosomal mobile genetic elements (MIN11 – 39 vs. MIN12 – 48), virulence factors (MIN-12 was distinguished by the presence of heat-stable toxin EAST-1) and content of chromosomal resistance determinants. The remaining extraintestinal colistin-resistant E. coli strains belonged to ST-533 (E. coli MIN6), ST-6856 (E. coli MIN9), ST-162 (E. coli MIN10), and ST-93 (E. coli MIN14). Moreover, whole-genome sequence-based phylogenomics of colistin-resistant E. coli strains is presented in Figure 4.

FIGURE 4

)] from GBDP distances calculated from genome sequences. The branch lengths are scaled in terms of GBDP distance formula d5.

Beta-Lactam Resistance

In the present study, all tested strains presented isolated resistance to amoxicillin-clavulanate. Three strains (MIN6, MIN12, MIN14) were equipped with multiple blaTEM–1 genes carried by various plasmids. E. coli MIN6 and MIN12 strain harbored duplicate blaTEM–1B genes, within two distinct mobile vectors, namely pMUB-MIN6-1 (89 956 bp), and MUB-MIN6-2 (56 897 bp) in E. coli MIN6, and pMUB-MIN12-1 (163 427 bp), and pMUB-MIN12-2 (95 526 bp) in E. coli MIN12. E. coli MIN14 possessed two TEM variants, namely blaTEM–1D and blaTEM–1B harbored by pMUB-MIN-14-2 (67 974 bp), and pMUB-MIN-14-3 (45 893 bp), respectively. Moreover, E. coli MIN9 possessed a single blaTEM–1a gene within the pMUB-MIN9-1 plasmid (283 245 bp). Interestingly, in case of E. coli MIN11, blaTEM–1B gene was present within the bacterial chromosome structure.

Fluoroquinolone Resistance

All tested E. coli strains, except MIN14, were ciprofloxacin-resistant due to multiple mutations of gyrA (p.S83L – 5/5 strains; p.D87N – 5/5 strains), parC (p.S80I – 3/5 strains; p.E84G – 1/5 strain; p.S80R – 1/5 strain), and parE (p.E460D – 1/5 strain; p.S458A – 1/5 strain) genes, coupled with additional acquired fluoroquinolone resistance gene, qnrB19, in case of MIN9 strain (pMUB-MIN9-7). The only ciprofloxacin-susceptible strain MIN14, possessed a plasmid-borne qnrS1 gene, which could be associated with low ciprofloxacin MICs.

Aminoglycoside Resistance

All tested E. coli strains were amikacin-susceptible, while E. coli MIN9 was the only tested strain that presented phenotypic resistance against gentamicin (MIC ≥ 16 mg/L), due to presence of aac(3″)-IIa (gene conferring resistance to gentamicin, apramycin, tobramycin, dibekacin, netilmicin, sisomicin) within pMUB-MIN9-1 (InCHI2A). Furthermore, all tested strains except MIN14, produced various aminoglycoside-resistance factors conferring resistance to spectinomycin, streptomycin [aadA1; aadA2b; aph(6)-Id; aph(3″)-Ib]; neomycin, kanamycin, lividomycin, paromomycin, ribostamycin (aph(3′)-Ia).

Folate Pathway Antagonist Resistance

All tested E. coli strains, except MIN14, presented trimethoprim/sulfamethoxazole-resistance, in accordance with WGS data screening for antimicrobial resistance determinants. E. coli MIN11 possesses the chromosomal trimethoprim-resistance gene, dfrA1, coupled with plasmidic sulfamethoxazole-resistance gene sul3. Moreover, remaining strains harbor plasmidic resistance genes, such as, dfrA1, dfrA14, dfrA15, sul1, sul2, and sul3.

Phenicol Resistance

Escherichia coli MIN9, MIN11, and MIN12 were also equipped with acquired genes conferring resistance to phenicols, namely chloramphenicol acetyltransferase gene catA1 (pMUB-MIN9-1), and MFS transporters cmlA1 (pMUB-MIN9-1; pMUB-MIN11-1; pMUB-MIN12-1) and floR (pMUB-MIN12-2).

Extraintestinal E. coli strains also possess a number of virulence factors, such as long polar fimbriae, heat-stable toxin EAST-1 or enterobactin siderophore. All genes encoding virulence factors are listed in Table 5.

TABLE 5

StrainSourceHospital wardVirulence factors
GeneFunction
M6, ST553,
–:H20		bedsore swabSecond Clinic of Nephrologygad – glutamate decarboxylasesurvival for at least 2 h in a strongly acidic environment
iss – increased serum survivalincreased complement resistance
lpfA – long polar fimbriaeadhesive factor contributing to intestine colonization
M9, ST6856, O176:H11abscess swabSecond General Surgery Clinicgad – glutamate decarboxylasesurvival for at least 2 h in a strongly acidic environment
M10, ST162, O126:H45pharyngeal swabHematology
Clinic		astA – heat-stable toxin EAST-1activation of membrane-bound guanylate cyclase, intracellular accumulation of cGMP
gad – glutamate decarboxylasesurvival for at least 2 h in a strongly acidic environment
iroN – enterobactin siderophoreacquiring iron for microbial systems
iss – increased serum survivalincreased complement resistance
lpfA – long polar fimbriaeadhesive factor contributing to intestine colonization
mchF – ABC transporter proteinantibiotic peptide (microcin) exporter
M11, ST10, O89m:H9bronchial aspirateNeurology Cliniccma – colicin Minhibition of peptidoglycan and O-antigen biosynthesis
gad – glutamate decarboxylasesurvival for at least 2 h in a strongly acidic environment
M12, ST10, O89m:H10wound swabVascular Surgery ClinicastA – heat-stable toxin EAST-1cGMP accumulation and loss of electrolytes and water from intestinal cells
cma – colicin Minhibition of peptidoglycan and O-antigen biosynthesis
gad – glutamate decarboxylasesurvival for at least 2 h in a strongly acidic environment
M14, ST93, O7:H4endotracheal tube secretionSecond General Surgery ClinicastA – heat-stable toxin EAST-1cGMP accumulation and loss of electrolytes and water from intestinal cells
gad – glutamate decarboxylasesurvival for at least 2 h in a strongly acidic environment
iss – increased serum survivalincreased complement resistance

Virulence factors in six extraintestinal colistin-resistant E. coli strains.

Discussion

In this paper we sought to investigate the mechanism of colistin-resistance in six extraintestinal E. coli strains isolated from patients hospitalized in Medical University Hospital, Bialystok, Poland. Full structures of bacterial chromosomes and plasmids were recovered with use of both short- and long-read sequencing technologies and Unicycler hybrid assembly. Results of antimicrobial resistance testing were in accordance with genomic and mobilome screening for antimicrobial resistance determinants. All tested extraintestinal E. coli strains harbored an IncX4 33.3 kbp plasmid pMUB-MCR, with the mobile pEtN transferase-encoding gene, mcr-1.1. Moreover, its influence on colistin-resistance phenotype was confirmed by transconjugation assays.

In the present study, we report the first detailed description of mcr-containing IncX4 plasmid harbored by clinical E. coli strains in Poland. In six extraintestinal E. coli strains, mcr-1.1 was found within a type IV secretion system (T4SS) contained within a 33.3 kbp IncX4 plasmid that is known to be involved in the disseminating of multiple mcr variants. It is widely accepted that some type IV secretion systems (T4SSs) in pathogenic Gram-negative bacteria are utilized in order to translocate virulence factors into the host cell, mediate downregulation of the hosts innate immune response genes and an increase bacterial uptake and survival within macrophages and epithelial cells (). Moreover, T4SSs could be also responsible for horizontal gene transfer (), thus contributing to genome plasticity and the evolution of pathogens through dissemination of antibiotic resistance and virulence genes (). Conjugative T4SSs are often encoded on self-transmissible plasmids coupled with genes that provide selective advantages for the cell such as antibiotic resistance, virulence factors or other metabolic functions that enhance survival (Wallden et al., 2010). The 33 kbp IncX4 plasmid was proven to be highly transmissible, showing 102–105-fold higher transfer frequencies relative to epidemic IncFII plasmid (; Xavier et al., 2016). Moreover, Lo and colleagues proved that 33 kbp IncX4 plasmid carriage is associated with relatively low fitness cost, which makes it a highly effective vehicle for drug resistance determinants (Wu et al., 2018). Interestingly, it has been also recently reported that IncX4 plasmid can be relatively easily and stably maintained in host bacteria (). In fact, IncX4 plasmids have been recently shown to harbor multiple mcr variants, CTX-M extended spectrum β-lactamase, as well as the 33.3 kbp IncX4 vehicles without any drug-resistance determinants (; ). Similar IncX4 mcr-containing plasmids are reported as increasingly disseminated mainly among E. coli isolates (Table 6), suggesting that it is becoming an “epidemic” plasmid, responsible for (i) disseminating colistin-resistance determinants between different E. coli clones, and (ii) circulating between environmental, industrial, and clinical settings. The phylogenomics of IncX4 plasmids bearing mobile pEtN transferase-encoding genes is presented in Figure 3.

TABLE 6

OriginOrganismCountryReferences
mcr-1.9ABFE. coli (swine)Portugal
mcr-1.1ABFE. coli ST-48; ST-131; ST-359; ST-1112; ST-2063 (chicken)Denmark
mcr-1.1clinicalS. Typhimurium ST-34United Kingdom
mcr-1.1ABF, clinicalSalmonellaspp.Portugal
mcr-1.2clinicalK. pneumoniaeST-512Italy
mcr-2ABFE. coli ST-10 (swine)BelgiumXavier et al., 2016
mcr-1.2natural environmentE. coli ST-10 (river)Italy
mcr-1.1
mcr-2		swine and poultry meatSalmonella spp.Belgium
mcr-1.2clinicalE. coliST-354ItalySimoni et al., 2018
mcr-1.1ABFE. coli ST-34; ST-757; ST-1494 (pig slurry)Estonia
mcr-1.1ABFE. coli ST-10 (boot swab); ST-1140 (boot swab);
ST-1011 (stable fly); ST-342 (manure); ST-10 (barn dog feces);		Germany
mcr-1.1clinicalE. coliST-1288France/Portugal
mcr-1.1ABFE. coli ST-641 (swine feces)GermanyPulss et al., 2017
mcr-1.1clinicalE. coliST-744/O89:H10PortugalTacão et al., 2017
mcr-1.1
mcr-1.2		chicken retail meat, clinicalE. coliST-5; ST-58Switzerland
mcr-1.1ABF, clinical, turkey and chicken meatE. coliST-48; ST-58; ST-156; ST-1431 (turkey);SwitzerlandZurfluh et al., 2017
mcr-1.1ABFE. coli ST-58; ST-69; ST-354; ST-453; ST-1081;
ST-1196; ST-5956 (turkey)		Czech Republic
E. coli ST-10; ST-93; ST-410; ST-744; ST-746;
ST-1385 (turkey)		Poland
E. coli ST-58; ST-162; ST1011 (turkey)Germany
mcr-1.1clinicalK. pneumoniaeST-45; ST-1112Portugal
mcr-1.1clinicalE. coliST-93Finland
mcr-1.1ABFE. coli ST-10; ST-48; ST-58; ST-69; ST-88; ST-90;
ST-93; ST-117; ST-155; ST-156; ST-162; ST-191;
ST-349; ST-354; ST-359; ST-533; ST-602; ST-617;
ST-624; ST-919; ST-949; ST-1167; ST-1170; ST-1196; ST-1564; ST-1611; ST-1851; ST-2001; ST-2509;
ST-2556; ST-6286; ST-7315 (turkey);
E. coli ST-37; ST-48; ST-57; ST-86; ST-189; ST-398;
ST-1011; E. coli ST-1303 (broiler); E. coli ST-359 (laying hen); E. coli ST-767 (pig)		PolandZaja̧c et al., 2019
mcr-1.1ABFSalmonella infantis (broilers);Italy
mcr-1.1ABFE. coli ST-1; ST-10; 118; 4274 (swine)Spain
mcr-1.1clinicalE. coliST-2448;K. pneumoniaeST-25China
mcr-1.1clinicalE. coliST-101Brazil
mcr-1.1ABFE. coli ST-1114; E. coli ST-167; E. coli ST-410; E. coli ST-90; E. coli ST-4429; E. coli ST-4656; E. coli ST-156; E. coli ST-54; E. coli ST-4463; E. coli ST-3331; E. coli ST-165; E. coli ST-1178; E. coli ST-1437; E. coli ST-2439; E. coli ST-48China
mcr-1.1wild birdsE. coli ST-10BrazilSellera et al., 2017
mcr-1.1clinicalE. coliST-167;E. coliST-10;E. coliST-2973;E. coliST-354;E. coliST-3028;E. coliST-354;E. coliST-156;E. coliST-1011;E. coliST-393;E. coliST-117;E. coliST-69;E. coliST-218;E. coliST-1193;E. coliST-853;E. coliST-58;E. coliST-44;E. coliST-131;E. coliST-117;E. coliST-457ChinaQuan et al., 2017
mcr-1.1clinicalSalmonellaTyphimuriumChina
mcr-1.1ABFE. coli ST-48; E. coli ST-4419;Brazil
mcr-1.1clinicalE. coli O157:H48United States
mcr-1.1natural environmentE. coli ST-1638; E. coli ST-46; E. coli ST-10; E. coli ST-101Brazil
mcr-1.1ABFE. coli ST-74; E. coli ST-1850 (commercial chicken meat)Brazil
mcr-1.1vegetablesE. coli ST-48 (lettuce)China
mcr-1.1hospital environmentE. coli ST-10; E. coli ST-410 (hospital sewage water)ChinaZhong et al., 2018
mcr-1.1ABFE. coli ST-155; E. coli ST-117 (chicken meat imported from Brazil)JapanNishino et al., 2017
E. coli ST-10 (pork meat imported from Spain)
mcr-1.1hospital environmentE. coli ST-1196; E. coli ST-165; E. coli ST-10; E. coli ST-155ChinaZhao et al., 2017
mcr-1.1clinicalK. pneumoniaeST-437Brazil
mcr-1.1clinicalE. coliST-10;E. coliST-46;E. coliST-167;E. coliST-410;E. coliST-3944;China
mcr-1.1clinicalE. coliST-201;E. coliST-486China
mcr-1.1clinicalK. pneumoniaeST-16;K. pneumoniaeST-45ThailandSrijan et al., 2018
mcr-1.1ABFE. coli ST-443BrazilPalmeira et al., 2018
mcr-1.1clinicalE. coliST-46;China
mcr-1.1clinicalK. pneumoniaeST-1296;E. coliST-782JapanTada et al., 2018
mcr-1.1public transportE. coli ST-2253, E. coli ST-101, E. coli ST-10, E. coli ST-37ChinaShen et al., 2018
mcr-1.1Chrysoma spp. fliesK. pneumoniae ST-43; E. coli ST-162; E. coli ST-1244; E. coli ST-10; E. coli ST-181; E. coli ST-549; E. coli ST-201; E. coli ST-218;ThailandYang et al., 2019
mcr-1.1ABFE. coli ST-278China
mcr-1.1clinicalE. coli ST-744; K. pneumoniae ST-101BrazilPerdigão Neto et al., 2019
mcr-1.1clinicalE. coliST-10;E. coliST-9;E. coliST-5442UruguayPapa-Ezdra et al., 2020
mcr-1.1shrimpV. parahaemolyticus VP181China
mcr-1.1municipal wastewaterE. coli ST-131; E. coli ST-135; E. coli ST-764; E. coli ST-453; E. coli ST-10; E. coli ST-871; E. coli ST-457Japan
mcr-1.1poultry, pork and turkey meatS. Typhimurium ST-19; S. Typhimurium ST-4556;BrazilRau et al., 2020
mcr-1.1raw retail chickenE. coli ST-1169; E. coli ST-371; E. coli ST-156;EgyptSadek et al., 2021
mcr-1.1raw turkey productsE. coli ST-10; E. coli ST-744; E. coli ST-1079; E. coli ST-354; E. coli ST-349; K. pneumoniae ST-11; K. pneumoniae ST-147;Czech RepublicZelendova et al., 2020
mcr-1.1ABF (poultry)E. coli ST-155; E. coli ST-7458; E. coli ST-1140;Lebanon
mcr-1.1healthy adultsK. pneumoniaeST-391;K. pneumoniaeST-37;China
mcr-1.1ABF (pigs)E. coli ST-746; E. coli ST-617;ChinaPeng et al., 2019
mcr-1.1fresh vegetablesE. coli ST-156;China
mcr-1.1clinical (outpatients)E. coliST-206;E. coliST-354;BrazilZamparette et al., 2020
mcr-1.1pigs; white storksE. coli ST-156; E. coli ST-10; E. coli ST-118; E. coli ST-224; E. coli ST-524; E. coli ST-42; E. coli ST-93; E. coli ST-1011;Spain
mcr-1.26
mcr-1.27		clinicalE. coliST-155;E. coliST-69;Germany
mcr-1.1retail meatsE. coli ST-38; E. coli ST-58; E. coli ST-443; E. coli ST-1737; E. coli ST-3889; E. coli ST-3998South Korea
mcr-1.1rainbow trout aquacultureE. coli ST-48; E. coli ST-101;Lebanon
mcr-1.1dog fecesE. coli ST-132;China
mcr-1.1retail meatsE. coli ST-367; E. coli ST-716; E. coli ST-471; E. coli ST-310; E. coli ST-342; E. coli ST-86;BelgiumTimmermans et al., 2021
mcr-2.1E. coli ST-638;
mcr-1.1retail meatsE. coli ST-1630; E. coli ST-48; E. coli ST-617;Laos
travelerE. coli ST-34; E. coli ST-10;

Global dissemination of mcr-harboring 33.3 kbp IncX4 plasmid.

ABF – animal breeding farms; underlined and bolded strains originated from clinical sources.

The first European environmental mcr-producing E. coli strain was obtained from Italian diarrhoeic veal calves in 2005 (), whereas the first European strain of clinical origin harboring plasmid-mediated colistin-resistance gene, was described in Denmark in a Salmonella Typhimurium ST34 strain with an mcr-3 variant ().

Here, we describe mobile pEtN transferase, mcr-1.1, encoded within a T4SS-containing 33.3 kbp IncX4 plasmid, pMUB-MCR. Similar IncX4 plasmids harboring different mcr variants were recently reported all over the world, with particular reference to animal breeding farms and environmental settings. Global dissemination of similar mcr-harboring IncX4 plasmids in Enterobacterales is presented in Table 6. So far, IncX4 mcr-harboring strains have been reported mainly in animal breeding farms, meat industry, and natural environments. Incidence of IncX4 mcr-harboring strains originating from clinical sources has been recently reported, in Switzerland (E. coli ST-5, ST-48), Portugal (K. pneumoniae ST-45, ST-1112, Salmonella spp.), Italy (E. coli ST-354; K. pneumoniae ST-512), France (E. coli ST-1288), Germany (E. coli ST-155; E. coli ST-69), Finland (E. coli ST-93), China (i. a. E. coli ST-2448; E. coli ST-167; E. coli ST-10), Brazil (E. coli ST-101; K. pneumoniae ST-437), United States of America (E. coli O157:H48), Thailand (K. pneumoniae ST-16; K. pneumoniae ST-45), Japan (K. pneumoniae ST-1296; E. coli ST-782), and United Kingdom (S. Typhimurium ST-34). Moreover, according to the current state of knowledge, E. coli is the major IncX4 clinical producer present in natural environments, animal breeding farms, as well as, in hospital settings. Recent research study performed by Zaja̧c et al. (2019) highlighted the importance of poultry farming, with particular emphasis on turkey, providing important reservoirs of mcr-1.1-carrying E. coli strains in Poland. The authors showed a wide diversity of IncX4 harboring strains, including 32 distinct sequence types (Table 6; Zaja̧c et al., 2019). Furthermore, the first clinical occurrence of a mcr-producing pathogen in Poland was reported by . Clinical E. coli ST-617 strain, a member of ST-10 complex, possesses ∼250 kbp plasmid carrying mcr-1.1 and blaCMY–2-containing IncA/C2 plasmids (∼160 kbp).

In this study, we described the following strains – two ST-10, ST-93, ST-162, ST-553, and ST-6856. Interestingly, ST-553 and ST-162 strains have been recently described as mcr-producers in turkeys from animal breeding farms in Poland and Germany, while ST-93 have been already reported in clinical settings in Finland. Moreover, colistin-resistant IncX4-producing E. coli ST-10 seems to be widely distributed globally, and were already reported in Belgium (swine), Italy (river), Germany (barn dog feces), Poland (turkeys), Spain (swine), Czech Republic (raw turkey products), Brazil (wild birds; natural environment), Thailand (Chrysoma spp. flies), China (hospital setting; public transport), Uruguay (clinical source), and Japan (retail meat; municipal wastewater). This is in accordance with a recent report published by , suggesting that E. coli ST-10 lineage, a sequence type known for its ubiquity in human fecal samples and in food samples, may function as an important reservoir of the mcr-1.1 gene ().

The enormous genome plasticity of Gram-negative bacteria enables the accumulation of many different mechanisms of resistance to various antimicrobial agents. As a result, the increased emergence of MDR or XDR pathogens considerably reduces the opportunities for effective treatments against these bacteria (; Ojdana et al., 2015). A number of recent reports highlights the importance of mcr dissemination in clinical MDR bacteria, especially among subpopulations of pathogens persisting in hospital environments. Co-occurrence of mcr and ESBLs (CTX-M-15), different carbapenemases (KPC-type, OXA-181), and other antimicrobial resistance determinants may possibly lead to formation of pandrug-resistant bacterial lineages (; ; ; ; Pulss et al., 2017; Tacão et al., 2017; ; ; ). In this study mcr coexisted with determinants of resistance to aminoglycosides [aph(3″)-Ib; aph(3″)-Ia; aph(6)-Id; aadA1; aac(3″)-IIa; aadA2b], chloramphenicol (catA1, cmlA1), β-lactams (blaTEM–1A; blaTEM–1B; blaTEM–1D), quinolones (qnrB19, qnrS1), sulfonamides (sul1, sul2, sul3), and trimethoprim (dfrA1, dfrA14, dfrA15). Interestingly, in case of E. coli MIN11, blaTEM–1B gene was present within the bacterial chromosome structure. proved that amoxicillin-clavulanate resistance with retained second-and third-generation cephalosporins susceptibility may be linked with blaTEM–1 overproduction (). Furthermore, Salverda et al. (2010) have recently proved that several amino acid substitutions were also identified as factors involved in increased resistance to β-lactam-clavulanate. Interestingly, in the case of tested extraintestinal E. coli subpopulation, the only ciprofloxacin-susceptible strain MIN14, possessed a plasmid-borne qnrS1 gene, which could be associated with low ciprofloxacin MICs. showed that qnrS1-possesing E. coli transconjugants showed low-level resistance to fluoroquinolones, with ciprofloxacin MIC ranging from 0.25 to 0.5 mg/L (). In our study, qnrS1-producing E. coli MIN14 strain was classified as ciprofloxacin susceptible, with MIC ≤ 0.25 mg/L.

In conclusion, the increasing prevalence of plasmids responsible for colistin-resistance, often carrying other determinants of drug resistance, may possibly lead to formation of pandrug-resistant bacterial lineages. Great effort needs to be taken to avoid further dissemination of plasmid-mediated colistin resistance among clinically relevant Gram-negative pathogens.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Data availability statement

The data presented in the study are deposited in the GenBank repository under BioProject number PRJNA700422 and accession numbers SAMN17831481 (E. coliMIN6—CP069692.1 for chromosome and CP069693.1–CP069700.1 for plasmids); SAMN17831482 (E. coliMIN9—CP069682.1 for chromosome and CP069683.1–CP069691.1 for plasmids); SAMN17831483 (E. coliMIN10—CP069677.1 for chromosome and CP069678.1–CP069681.1 for plasmids); SAMN17831484 (E. coliMIN11—CP069666.1 for chromosome and CP069667.1–CP069676.1 for plasmids); SAMN17831485 (E. coliMIN12—CP069657.1 for chromosome and CP069658.1–CP069665.1 for plasmids); and SAMN17831486 (E. coliMIN14—CP069646.1 for chromosome and CP069647.1–CP069656.1 for plasmids).

Ethics statement

This molecular investigation uses strains obtained from collection of strains deposited in Department of Microbiological Diagnostics and Infectious Immunology, Medical University of Bialystok, Poland. The Bioethics Commission of the Medical University in Bialystok did not require the study to be reviewed or approved by an ethics committee because apart from the strains from the Department’s collection, no data enabling patient identification was used in the study.

Author contributions

PiM, DS, JN, and ET substantially contributed to the conception of the submitted research manuscript, designing and validation of the experiments, and data acquisition and interpretation (antimicrobial susceptibility testing, short-read sequencing, long-read sequencing, and preparation of the figures and tables). PaM, AG, AS, and DS wrote the main manuscript. PiM was responsible for library preparation, WGS, and bioinformatics. PaM, DG, DI, PS, AZ, PR, PW, THa, IS, KM, RC, and JD contributed to the validation of the designed experiments and data acquisition and interpretation. THr, BK, JK, JG, SC, and PR were responsible for the medical care of the patient. All authors reviewed the manuscript.

Funding

This work was financed by the MINIATURA research project (2017/01/X/NZ6/01852 - National Science Center, Poland), and supported by the Medical University of Bialystok statutory subsidy (SUB/1/DN/19/005/2222).

Acknowledgments

We thank Steven J. Snodgrass for editorial assistance.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Footnotes

1.^https://itol.embl.de/

References

  • 1

    AlikhanN.-F.PettyN. K.Ben ZakourN. L.BeatsonS. A. (2011). BLAST ring image generator (BRIG): simple prokaryote genome comparisons.BMC Genomics12:402. 10.1186/1471-2164-12-402

  • 2

    AllouN.CambauE.MassiasL.ChauF.FantinB. (2009). Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.Antimicrob. Agents Chemother.534292–4297. 10.1128/AAC.01664-08

  • 3

    BaiF.LiX.NiuB.ZhangZ.MalakarP. K.LiuH.et al (2018). A mcr-1-carrying conjugative IncX4 plasmid in colistin-resistant Escherichia coli ST278 strain isolated from dairy cow feces in Shanghai, China.Front. Microbiol.9:2833. 10.3389/fmicb.2018.02833

  • 4

    BaronS.HadjadjL.RolainJ.-M.OlaitanA. O. (2016). Molecular mechanisms of polymyxin resistance: knowns and unknowns.Int. J. Antimicrob. Agents48583–591. 10.1016/j.ijantimicag.2016.06.023

  • 5

    BeyrouthyR.RobinF.LesseneA.LacombatI.DortetL.NaasT.et al (2017). MCR-1 and OXA-48 In Vivo acquisition in KPC-producing Escherichia coli after colistin treatment.Antimicrob. Agents Chemother.61:e02540-16. 10.1128/AAC.02540-16

  • 6

    BolgerA. M.LohseM.UsadelB. (2014). Trimmomatic: a flexible trimmer for Illumina sequence data.Bioinformatics302114–2120. 10.1093/bioinformatics/btu170

  • 7

    BortolaiaV.KaasR. S.RuppeE.RobertsM. C.SchwarzS.CattoirV.et al (2020). ResFinder 4.0 for predictions of phenotypes from genotypes.J. Antimicrob. Chemother.753491–3500. 10.1093/jac/dkaa345

  • 8

    BrauerA.TellingK.LahtM.KalmusP.LutsarI.RemmM.et al (2016). Plasmid with colistin resistance gene mcr-1 in extended-spectrum-β-lactamase-producing Escherichia coli strains isolated from pig slurry in Estonia.Antimicrob. Agents Chemother.606933–6936. 10.1128/AAC.00443-16

  • 9

    BrettinT.DavisJ. J.DiszT.EdwardsR. A.GerdesS.OlsenG. J.et al (2015). RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes.Sci. Rep.5:8365. 10.1038/srep08365

  • 10

    CaltagironeM.NucleoE.SpallaM.ZaraF.NovazziF.MarchettiV. M.et al (2017). Occurrence of extended spectrum β-lactamases, KPC-Type, and MCR-1.2-producing Enterobacteriaceae from wells, River water, and wastewater treatment plants in Oltrepò Pavese Area, Northern Italy.Front. Microbiol.8:2232. 10.3389/fmicb.2017.02232

  • 11

    CamposJ.CristinoL.PeixeL.AntunesP. (2016). MCR-1 in multidrug-resistant and copper-tolerant clinically relevant Salmonella 1,4,[5],12:i:- and S. Rissen clones in Portugal, 2011 to 2015.Euro Surveill.21:30270. 10.2807/1560-7917.ES.2016.21.26.30270

  • 12

    CarattoliA.ZankariE.García-FernándezA.Voldby LarsenM.LundO.VillaL.et al (2014). In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing.Antimicrob. Agents Chemother.583895–3903. 10.1128/AAC.02412-14

  • 13

    CarforaV.AlbaP.LeekitcharoenphonP.BallaròD.CordaroG.Di MatteoP.et al (2018). Colistin resistance mediated by mcr-1 in ESBL-producing, multidrug Resistant Salmonella infantis in broiler chicken industry, Italy (2016-2017).Front. Microbiol.9:1880. 10.3389/fmicb.2018.01880

  • 14

    ChanW.-S.AuC.-H.HoD. N.ChanT.-L.MaE. S.-K.TangB. S.-F. (2018). Prospective study on human fecal carriage of Enterobacteriaceae possessing mcr-1 and mcr-2 genes in a regional hospital in Hong Kong.BMC Infect. Dis.18:81. 10.1186/s12879-018-2987-y

  • 15

    ChenF.ZhangW.SchwarzS.ZhuY.LiR.HuaX.et al (2019). Genetic characterization of an MDR/virulence genomic element carrying two T6SS gene clusters in a clinical Klebsiella pneumoniae isolate of swine origin.J. Antimicrob. Chemother.741539–1544. 10.1093/jac/dkz093

  • 16

    CuiM.ZhangJ.GuZ.LiR.ChanE. W.-C.YanM.et al (2017). Prevalence and molecular characterization of mcr-1-positive Salmonella strains recovered from clinical specimens in China.Antimicrob. Agents Chemother.61:e02471-16. 10.1128/AAC.02471-16

  • 17

    DalmolinT. V.MartinsA. F.ZavasckiA. P.de Lima-MoralesD.BarthA. L. (2018). Acquisition of the mcr-1 gene by a high-risk clone of KPC-2-producing Klebsiella pneumoniae ST437/CC258, Brazil.Diagn. Microbiol. Infect. Dis.90132–133. 10.1016/j.diagmicrobio.2017.09.016

  • 18

    Di ConzaJ. A.BadaraccoA.AyalaJ.RodríguezC.FamigliettiA.GutkindG. O. (2014). β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene.Rev. Argent. Microbiol.46210–217. 10.1016/S0325-7541(14)70075-6

  • 19

    Di PilatoV.ArenaF.TasciniC.CannatelliA.Henrici De AngelisL.FortunatoS.et al (2016). mcr-1.2, a new mcr variant carried on a transferable plasmid from a colistin-Resistant KPC Carbapenemase-producing Klebsiella pneumoniae strain of sequence Type 512.Antimicrob. Agents Chemother.605612–5615. 10.1128/AAC.01075-16

  • 20

    DonàV.BernasconiO. J.PiresJ.CollaudA.OvereschG.RametteA.et al (2017). Heterogeneous genetic location of mcr-1 in colistin-resistant Escherichia coli isolates from humans and retail chicken meat in Switzerland: emergence of mcr-1-carrying IncK2 plasmids.Antimicrob. Agents Chemother.61:e01245-17. 10.1128/AAC.01245-17

  • 21

    DoumithM.GodboleG.AshtonP.LarkinL.DallmanT.DayM.et al (2016). Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales.J. Antimicrob. Chemother.712300–2305. 10.1093/jac/dkw093

  • 22

    DuC.FengY.WangG.ZhangZ.HuH.YuY.et al (2020). Co-occurrence of the mcr-1.1 and mcr-3.7 Genes in a multidrug-resistant Escherichia coli Isolate from China.Infect. Drug Resist.133649–3655. 10.2147/IDR.S268787

  • 23

    El-Sayed AhmedM. A. E.-G.ZhongL.-L.ShenC.YangY.DoiY.TianG.-B. (2020). Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019).Emerg. Microbes Infect.9868–885. 10.1080/22221751.2020.1754133

  • 24

    FengS.ShenC.ChenH.ZhengX.XiaY.ZhongL.-L.et al (2018). Co-production of MCR-1 and NDM-5 in Escherichia coli isolated from a colonization case of inpatient.Infect. Drug Resist.111157–1161. 10.2147/IDR.S171164

  • 25

    FernandesM. R.McCullochJ. A.VianelloM. A.MouraQ.Pérez-ChaparroP. J.EspositoF.et al (2016). First report of the globally disseminated IncX4 plasmid carrying the mcr-1 gene in a colistin-resistant Escherichia coli sequence Type 101 isolate from a human infection in Brazil.Antimicrob. Agents Chemother.606415–6417. 10.1128/AAC.01325-16

  • 26

    FernandesM. R.SelleraF. P.EspositoF.SabinoC. P.CerdeiraL.LincopanN. (2017). Colistin-Resistant mcr-1-Positive Escherichia coli on public beaches, an infectious threat emerging in recreational waters.Antimicrob. Agents Chemother.61:e00234-17. 10.1128/AAC.00234-17

  • 27

    Garcia-GraellsC.De KeersmaeckerS. C. J.VannesteK.PochetB.VermeerschK.RoosensN.et al (2018). Detection of plasmid-mediated colistin resistance, mcr-1 and mcr-2 genes, in Salmonella spp. Isolated from food at retail in Belgium from 2012 to 2015.Foodborne Pathog. Dis.15114–117. 10.1089/fpd.2017.2329

  • 28

    García-MeniñoI.Díaz-JiménezD.GarcíaV.de ToroM.Flament-SimonS. C.BlancoJ.et al (2019). Genomic characterization of prevalent mcr-1, mcr-4, and mcr-5 Escherichia coli within swine enteric Colibacillosis in Spain.Front. Microbiol.10:2469. 10.3389/fmicb.2019.02469

  • 29

    GelbíčováT.BarákováA.FlorianováM.JamborováI.ZelendováM.PospíšilováL.et al (2019). Dissemination and comparison of genetic determinants of mcr-mediated Colistin resistance in Enterobacteriaceae via retailed raw meat products.Front. Microbiol.10:2824. 10.3389/fmicb.2019.02824

  • 30

    GokulanK.KhareS.RooneyA. W.HanJ.LynneA. M.FoleyS. L. (2013). Impact of plasmids, including those encodingVirB4/D4 type IV secretion systems, on Salmonella enterica serovar Heidelberg virulence in macrophages and epithelial cells.PLoS One8:e77866. 10.1371/journal.pone.0077866

  • 31

    Gröndahl-Yli-HannukselaK.LönnqvistE.KallonenT.LindholmL.JalavaJ.Rantakokko-JalavaK.et al (2018). The first human report of mobile colistin resistance gene, mcr-1, in Finland.APMIS126413–417. 10.1111/apm.12834

  • 32

    GuentherS.FalgenhauerL.SemmlerT.ImirzaliogluC.ChakrabortyT.RoeslerU.et al (2017). Environmental emission of multiresistant Escherichia coli carrying the colistin resistance gene mcr-1 from German swine farms.J. Antimicrob. Chemother.721289–1292. 10.1093/jac/dkw585

  • 33

    HaenniM.PoirelL.KiefferN.ChâtreP.SarasE.MétayerV.et al (2016). Co-occurrence of extended spectrum β lactamase and MCR-1 encoding genes on plasmids.Lancet Infect. Dis.16281–282. 10.1016/S1473-3099(16)00007-4

  • 34

    HasmanH.HammerumA. M.HansenF.HendriksenR. S.OlesenB.AgersøY.et al (2015). Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015.Euro Surveill.20:30085. 10.2807/1560-7917.ES.2015.20.49.30085

  • 35

    HassanJ.EddineR. Z.MannD.LiS.DengX.SaoudI. P.et al (2020). The mobile colistin resistance gene, mcr-1.1, is carried on IncX4 plasmids in multidrug resistant E. coli isolated from rainbow trout aquaculture.Microorganisms8:1636. 10.3390/microorganisms8111636

  • 36

    HayashiW.TanakaH.TaniguchiY.IimuraM.SogaE.KuboR.et al (2019). Acquisition of mcr-1 and cocarriage of virulence genes in avian pathogenic Escherichia coli isolates from municipal wastewater influents in Japan.Appl. Environ. Microbiol.85:e001661-19. 10.1128/AEM.01661-19

  • 37

    IzdebskiR.BaraniakA.BojarskaK.UrbanowiczP.FiettJ.Pomorska-WesołowskaM.et al (2016). Mobile MCR-1-associated resistance to colistin in Poland.J. Antimicrob. Chemother.712331–2333. 10.1093/jac/dkw261

  • 38

    JuhasM.CrookD. W.HoodD. W. (2008). Type IV secretion systems: tools of bacterial horizontal gene transfer and virulence.Cell. Microbiol.102377–2386. 10.1111/j.1462-5822.2008.01187.x

  • 39

    KassemI. I.MannD.LiS.DengX. (2021). Draft genome sequences and resistome analysis of multidrug-resistant mcr-1-harbouring Escherichia coli isolated from pre-harvest poultry in Lebanon.J. Glob. Antimicrob. Resist.25114–116. 10.1016/j.jgar.2021.03.001

  • 40

    KayeK. S.PogueJ. M.TranT. B.NationR. L.LiJ. (2016). Agents of last resort: polymyxin resistance.Infect. Dis. Clin. North Am.30391–414. 10.1016/j.idc.2016.02.005

  • 41

    KimS.KimH.KangH.-S.KimY.KimM.KwakH.et al (2020). Prevalence and genetic characterization of mcr-1-positive Escherichia coli isolated from retail meats in South Korea.J. Microbiol. Biotechnol.301862–1869. 10.4014/jmb.2007.07008

  • 42

    KongL.-H.LeiC.-W.MaS.-Z.JiangW.LiuB.-H.WangY.-X.et al (2017). Various sequence types of Escherichia coli isolates coharboring blaNDM-5 and mcr-1 genes from a commercial swine farm in China.Antimicrob. Agents Chemother.61:e02167-16. 10.1128/AAC.02167-16

  • 43

    LefortV.DesperR.GascuelO. (2015). FastME 2.0: a comprehensive, accurate, and fast distance-based phylogeny inference program.Mol. Biol. Evol.322798–2800. 10.1093/molbev/msv150

  • 44

    LeiT.ZhangJ.JiangF.HeM.ZengH.ChenM.et al (2019). First detection of the plasmid-mediated colistin resistance gene mcr-1 in virulent Vibrio parahaemolyticus.Int. J. Food Microbiol.308:108290. 10.1016/j.ijfoodmicro.2019.108290

  • 45

    LetunicI.BorkP. (2021). Interactive tree of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation.Nucleic Acids Res.49W293–W296. 10.1093/nar/gkab301

  • 46

    LiA.YangY.MiaoM.ChavdaK. D.MediavillaJ. R.XieX.et al (2016). Complete sequences of mcr-1-harboring plasmids from extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacteriaceae.Antimicrob. Agents Chemother.604351–4354. 10.1128/AAC.00550-16

  • 47

    LindseyR. L.BatraD.RoweL.LoparevV. N.StriplingD.Garcia-ToledoL.et al (2017). High-quality genome sequence of an Escherichia coli O157 strain carrying an mcr-1 resistance gene isolated from a patient in the United States.Genome Announc.5:e01725-16. 10.1128/genomeA.01725-16

  • 48

    LitrupE.KiilK.HammerumA. M.RoerL.NielsenE. M.TorpdahlM. (2017). Plasmid-borne colistin resistance gene mcr-3 in Salmonella isolates from human infections, Denmark, 2009-17.Euro Surveill.22:30587. 10.2807/1560-7917.ES.2017.22.31.30587

  • 49

    LiuB.-T.SongF.-J. (2019). Emergence of two Escherichia coli strains co-harboring mcr-1 and blaNDM in fresh vegetables from China.Infect. Drug Resist.122627–2635. 10.2147/IDR.S211746

  • 50

    LiuY.-Y.WangY.WalshT. R.YiL.-X.ZhangR.SpencerJ.et al (2016). Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.Lancet Infect. Dis.16161–168. 10.1016/S1473-3099(15)00424-7

  • 51

    LivermoreD. M.WarnerM.MushtaqS.DoumithM.ZhangJ.WoodfordN. (2011). What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline.Int. J. Antimicrob. Agents37415–419. 10.1016/j.ijantimicag.2011.01.012

  • 52

    LoW.-U.ChowK.-H.LawP. Y.NgK.-Y.CheungY.-Y.LaiE. L.et al (2014). Highly conjugative IncX4 plasmids carrying blaCTX-M in Escherichia coli from humans and food animals.J. Med. Microbiol.63835–840. 10.1099/jmm.0.074021-0

  • 53

    LuJ.DongN.LiuC.ZengY.SunQ.ZhouH.et al (2020). Prevalence and molecular epidemiology of mcr-1-positive Klebsiella pneumoniae in healthy adults from China.J. Antimicrob. Chemother.752485–2494. 10.1093/jac/dkaa210

  • 54

    LuoJ.YaoX.LvL.DoiY.HuangX.HuangS.et al (2017). Emergence of mcr-1 in Raoultella ornithinolytica and Escherichia coli isolates from retail vegetables in China.Antimicrob. Agents Chemother.61:e01139-17. 10.1128/AAC.01139-17

  • 55

    LuoQ.YuW.ZhouK.GuoL.ShenP.LuH.et al (2017). Molecular epidemiology and colistin resistant mechanism of mcr-positive and mcr-negative clinical isolated Escherichia coli.Front. Microbiol.8:2262. 10.3389/fmicb.2017.02262

  • 56

    ManageiroV.ClementeL.RomãoR.SilvaC.VieiraL.FerreiraE.et al (2019). IncX4 plasmid carrying the new mcr-1.9 gene variant in a CTX-M-8-producing Escherichia coli isolate recovered from swine.Front. Microbiol.10:367. 10.3389/fmicb.2019.00367

  • 57

    MatamorosS.van HattemJ. M.ArcillaM. S.WillemseN.MellesD. C.PendersJ.et al (2017). Global phylogenetic analysis of Escherichia coli and plasmids carrying the mcr-1 gene indicates bacterial diversity but plasmid restriction.Sci. Rep.7:15364. 10.1038/s41598-017-15539-7

  • 58

    Meier-KolthoffJ. P.GökerM. (2019). TYGS is an automated high-throughput platform for state-of-the-art genome-based taxonomy.Nat. Commun.10:2182. 10.1038/s41467-019-10210-3

  • 59

    Meier-KolthoffJ. P.AuchA. F.KlenkH.-P.GökerM. (2013). Genome sequence-based species delimitation with confidence intervals and improved distance functions.BMC Bioinformatics14:60. 10.1186/1471-2105-14-60

  • 60

    MendesA. C.NovaisÂCamposJ.RodriguesC.SantosC.AntunesP.et al (2018). mcr-1 in carbapenemase-producing Klebsiella pneumoniae with hospitalized patients, Portugal, 2016-2017.Emerging Infect. Dis.24762–766. 10.3201/eid2404.171787

  • 61

    Migura-GarciaL.González-LópezJ. J.Martinez-UrtazaJ.Aguirre SánchezJ. R.Moreno-MingoranceA.Perez de RozasA.et al (2019). mcr-Colistin resistance genes mobilized by IncX4, IncHI2, and IncI2 plasmids in Escherichia coli of pigs and white stork in Spain.Front. Microbiol.10:3072. 10.3389/fmicb.2019.03072

  • 62

    MonteD. F.FernandesM. R.CerdeiraL.de SouzaT. A.MemA.FrancoB. D. G. M.et al (2017a). Draft genome sequences of colistin-resistant MCR-1-producing Escherichia coli ST1850 and ST74 strains isolated from commercial chicken meat.Genome Announc.5:e00329-17. 10.1128/genomeA.00329-17

  • 63

    MonteD. F.MemA.FernandesM. R.CerdeiraL.EspositoF.GalvãoJ. A.et al (2017b). Chicken meat as a reservoir of colistin-Resistant Escherichia coli strains carrying mcr-1 genes in South America.Antimicrob. Agents Chemother.61:e02718-16. 10.1128/AAC.02718-16

  • 64

    MoserA. I.KuenzliE.Campos-MaduenoE. I.BüdelT.RattanavongS.VongsouvathM.et al (2021). Antimicrobial-resistant Escherichia coli strains and their plasmids in people, poultry, and chicken meat in laos.Front. Microbiol.12:708182. 10.3389/fmicb.2021.708182

  • 65

    NangS. C.LiJ.VelkovT. (2019). The rise and spread of mcr plasmid-mediated polymyxin resistance.Crit. Rev. Microbiol.45131–161. 10.1080/1040841X.2018.1492902

  • 66

    NeumannB.RackwitzW.HunfeldK.-P.FuchsS.WernerG.PfeiferY. (2020). Genome sequences of two clinical Escherichia coli isolates harboring the novel colistin-resistance gene variants mcr-1.26 and mcr-1.27.Gut Pathog.12:40. 10.1186/s13099-020-00375-4

  • 67

    NikaidoH. (2003). Molecular basis of bacterial outer membrane permeability revisited.Microbiol. Mol. Biol. Rev.67593–656. 10.1128/mmbr.67.4.593-656.2003

  • 68

    NishinoY.ShimojimaY.SuzukiY.IdaM.FukuiR.KurodaS.et al (2017). Detection of the mcr-1 gene in colistin-resistant Escherichia coli from retail meat in Japan.Microbiol. Immunol.61554–557. 10.1111/1348-0421.12549

  • 69

    OjdanaD.SachaP.OlszańskaD.MajewskiP.WieczorekP.JaworowskaJ.et al (2015). First report of Klebsiella pneumoniae-carbapenemase-3-producing Escherichia coli ST479 in Poland.Biomed Res. Int.2015:256028. 10.1155/2015/256028

  • 70

    OlaitanA. O.MorandS.RolainJ.-M. (2014). Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria.Front. Microbiol.5:643. 10.3389/fmicb.2014.00643

  • 71

    Osei SekyereJ. (2019). Mcr colistin resistance gene: a systematic review of current diagnostics and detection methods.Microbiologyopen8:e00682. 10.1002/mbo3.682

  • 72

    PalmeiraJ. D.FerreiraH.MadecJ.-Y.HaenniM. (2018). Draft genome of a ST443 mcr-1- and blaCTX-M-2-carrying Escherichia coli from cattle in Brazil.J. Glob. Antimicrob. Resist.13269–270. 10.1016/j.jgar.2018.05.010

  • 73

    Papa-EzdraR.Grill DiazF.VieytesM.García-FulgueirasV.CaiataL.ÁvilaP.et al (2020). First three Escherichia coli isolates harbouring mcr-1 in Uruguay.J. Glob. Antimicrob. Resist.20187–190. 10.1016/j.jgar.2019.07.016

  • 74

    PartridgeS. R.Di PilatoV.DoiY.FeldgardenM.HaftD. H.KlimkeW.et al (2018). Proposal for assignment of allele numbers for mobile colistin resistance (mcr) genes.J. Antimicrob. Chemother.732625–2630. 10.1093/jac/dky262

  • 75

    PengZ.LiX.HuZ.LiZ.LvY.LeiM.et al (2019). Characteristics of carbapenem-resistant and colistin-resistant Escherichia coli Co-producing NDM-1 and MCR-1 from pig farms in China.Microorganisms7:482. 10.3390/microorganisms7110482

  • 76

    Perdigão NetoL. V.CorscaddenL.MartinsR. C. R.NaganoD. S.CunhaM. P. V.NevesP. R.et al (2019). Simultaneous colonization by Escherichia coli and Klebsiella pneumoniae harboring mcr-1 in Brazil.Infection47661–664. 10.1007/s15010-019-01309-2

  • 77

    Pham ThanhD.Thanh TuyenH.Nguyen Thi NguyenT.Chung TheH.WickR. R.ThwaitesG. E.et al (2016). Inducible colistin resistance via a disrupted plasmid-borne mcr-1 gene in a 2008 Vietnamese Shigella sonnei isolate.J. Antimicrob. Chemother.712314–2317. 10.1093/jac/dkw173

  • 78

    PulssS.SemmlerT.Prenger-BerninghoffE.BauerfeindR.EwersC. (2017). First report of an Escherichia coli strain from swine carrying an OXA-181 carbapenemase and the colistin resistance determinant MCR-1.Int. J. Antimicrob. Agents50232–236. 10.1016/j.ijantimicag.2017.03.014

  • 79

    QuanJ.LiX.ChenY.JiangY.ZhouZ.ZhangH.et al (2017). Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study.Lancet Infect. Dis.17400–410. 10.1016/S1473-3099(16)30528-X

  • 80

    RauR. B.de Lima-MoralesD.WinkP. L.RibeiroA. R.BarthA. L. (2020). Salmonella enterica mcr-1 positive from food in Brazil: detection and characterization.Foodborne Pathog. Dis.17202–208. 10.1089/fpd.2019.2700

  • 81

    RoerL.HansenF.SteggerM.SönksenU. W.HasmanH.HammerumA. M. (2017). Novel mcr-3 variant, encoding mobile colistin resistance, in an ST131 Escherichia coli isolate from bloodstream infection, Denmark, 2014.Euro Surveill.22:30584.

  • 82

    SadekM.Ortiz de la RosaJ. M.Abdelfattah MakyM.Korashe DandrawyM.NordmannP.PoirelL. (2021). Genomic features of MCR-1 and extended-spectrum β-lactamase-producing Enterobacterales from retail raw chicken in Egypt.Microorganisms9:195. 10.3390/microorganisms9010195

  • 83

    SalverdaM. L. M.De VisserJ. A. G. M.BarlowM. (2010). Natural evolution of TEM-1 β-lactamase: experimental reconstruction and clinical relevance.FEMS Microbiol. Rev.341015–1036. 10.1111/j.1574-6976.2010.00222.x

  • 84

    SelleraF. P.FernandesM. R.SartoriL.CarvalhoM. P. N.EspositoF.NascimentoC. L.et al (2017). Escherichia coli carrying IncX4 plasmid-mediated mcr-1 and blaCTX-M genes in infected migratory Magellanic penguins (Spheniscus magellanicus).J. Antimicrob. Chemother.721255–1256. 10.1093/jac/dkw543

  • 85

    ShenC.FengS.ChenH.DaiM.PatersonD. L.ZhengX.et al (2018). Transmission of mcr-1-producing multidrug-resistant Enterobacteriaceae in Public transportation in Guangzhou, China.Clin. Infect. Dis.67S217–S224. 10.1093/cid/ciy661

  • 86

    ShenZ.WangY.ShenY.ShenJ.WuC. (2016). Early emergence of mcr-1 in Escherichia coli from food-producing animals.Lancet Infect. Dis.16:293. 10.1016/S1473-3099(16)00061-X

  • 87

    SimoniS.MorroniG.BrencianiA.VincenziC.CirioniO.CastellettiS.et al (2018). Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli.Diagn. Microbiol. Infect. Dis.9166–68. 10.1016/j.diagmicrobio.2017.12.015

  • 88

    SrijanA.MargulieuxK. R.RuekitS.SnesrudE.MaybankR.SerichantalergsO.et al (2018). Genomic characterization of nonclonal mcr-1-positive multidrug-resistant Klebsiella pneumoniae from clinical samples in Thailand.Microb. Drug Resist.24403–410. 10.1089/mdr.2017.0400

  • 89

    TacãoM.TavaresR. D. S.TeixeiraP.RoxoI.RamalheiraE.FerreiraS.et al (2017). mcr-1 and blaKPC-3 in Escherichia coli sequence Type 744 after Meropenem and Colistin therapy.Portugal. Emerging Infect. Dis.231419–1421. 10.3201/eid2308.170162

  • 90

    TadaT.UechiK.NakasoneI.NakamatsuM.SatouK.HiranoT.et al (2018). Emergence of IncX4 plasmids encoding mcr-1 in a clinical isolate of Klebsiella pneumoniae in Japan.Int. J. Infect. Dis.7598–100. 10.1016/j.ijid.2018.08.011

  • 91

    TimmermansM.WattiauP.DenisO.BolandC. (2021). Colistin resistance genes mcr-1 to mcr-5, including a case of triple occurrence (mcr-1, -3 and -5), in Escherichia coli isolates from faeces of healthy pigs, cattle and poultry in Belgium, 2012-2016.Int. J. Antimicrob. Agents57:106350. 10.1016/j.ijantimicag.2021.106350

  • 92

    TorpdahlM.HasmanH.LitrupE.SkovR. L.NielsenE. M.HammerumA. M. (2017). Detection of mcr-1-encoding plasmid-mediated colistin-resistant Salmonella isolates from human infection in Denmark.Int. J. Antimicrob. Agents49261–262. 10.1016/j.ijantimicag.2016.11.010

  • 93

    WalldenK.Rivera-CalzadaA.WaksmanG. (2010). Type IV secretion systems: versatility and diversity in function.Cell. Microbiol.121203–1212. 10.1111/j.1462-5822.2010.01499.x

  • 94

    WickR. R.JuddL. M.GorrieC. L.HoltK. E. (2017). Unicycler: resolving bacterial genome assemblies from short and long sequencing reads.PLoS Comput. Biol.13:e1005595. 10.1371/journal.pcbi.1005595

  • 95

    WuR.YiL.-X.YuL.-F.WangJ.LiuY.ChenX.et al (2018). Fitness advantage of mcr-1-bearing IncI2 and IncX4 plasmids in Vitro.Front. Microbiol.9:331. 10.3389/fmicb.2018.00331

  • 96

    XavierB. B.LammensC.RuhalR.Kumar-SinghS.ButayeP.GoossensH.et al (2016). Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016.Euro Surveill.21:30280. 10.2807/1560-7917.ES.2016.21.27.30280

  • 97

    YangQ. E.TansawaiU.AndreyD. O.WangS.WangY.SandsK.et al (2019). Environmental dissemination of mcr-1 positive Enterobacteriaceae by Chrysomya spp. (common blowfly): an increasing public health risk.Environ. Int.122281–290. 10.1016/j.envint.2018.11.021

  • 98

    Zaja̧cM.SztromwasserP.BortolaiaV.LeekitcharoenphonP.CavacoL. M.Ziȩtek-BarszczA.et al (2019). Corrigendum: occurrence and characterization of mcr-1-positive Escherichia coli isolated from food-producing animals in Poland, 2011-2016.Front. Microbiol.10:2816. 10.3389/fmicb.2019.02816

  • 99

    ZamparetteC. P.SchornerM.CamposE.MouraQ.CerdeiraL.TartariD. C.et al (2020). IncX4 plasmid-mediated mcr-1.1 in polymyxin-resistant Escherichia coli from outpatients in Santa Catarina, Southern Brazil.Microb. Drug Resist.261326–1333. 10.1089/mdr.2019.0203

  • 100

    ZelendovaM.PapagiannitsisC. C.ValcekA.MedveckyM.BitarI.HrabakJ.et al (2020). Characterization of the complete nucleotide sequences of mcr-1-encoding plasmids from Enterobacterales isolates in retailed raw meat products from the Czech Republic.Front. Microbiol.11:604067. 10.3389/fmicb.2020.604067

  • 101

    ZengK.-J.DoiY.PatilS.HuangX.TianG.-B. (2016). Emergence of the plasmid-mediated mcr-1 gene in colistin-resistant Enterobacter aerogenes and Enterobacter cloacae.Antimicrob. Agents Chemother.603862–3863. 10.1128/AAC.00345-16

  • 102

    ZhaoF.FengY.LüX.McNallyA.ZongZ. (2017). Remarkable diversity of Escherichia coli carrying mcr-1 from hospital sewage with the identification of Two New mcr-1 variants.Front. Microbiol.8:2094. 10.3389/fmicb.2017.02094

  • 103

    ZhongL.-L.PhanH. T. T.ShenC.VihtaK.-D.SheppardA. E.HuangX.et al (2018). High rates of human fecal carriage of mcr-1-positive multidrug-resistant Enterobacteriaceae emerge in China in association with successful plasmid families.Clin. Infect. Dis.66676–685. 10.1093/cid/cix885

  • 104

    ZurfluhK.Nüesch-InderbinenM.KlumppJ.PoirelL.NordmannP.StephanR. (2017). Key features of mcr-1-bearing plasmids from Escherichia coli isolated from humans and food.Antimicrob. Resist. Infect. Control6:91. 10.1186/s13756-017-0250-8

Summary

Keywords

colistin-resistance, IncX4 plasmid, mcr-1.1, extraintestinal E. coli, plasmid

Citation

Majewski P, Gutowska A, Smith DGE, Hauschild T, Majewska P, Hryszko T, Gizycka D, Kedra B, Kochanowicz J, Glowiński J, Drewnowska J, Swiecicka I, Sacha PT, Wieczorek P, Iwaniuk D, Sulewska A, Charkiewicz R, Makarewicz K, Zebrowska A, Czaban S, Radziwon P, Niklinski J and Tryniszewska EA (2021) Plasmid Mediated mcr-1.1 Colistin-Resistance in Clinical Extraintestinal Escherichia coli Strains Isolated in Poland. Front. Microbiol. 12:547020. doi: 10.3389/fmicb.2021.547020

Received

30 March 2020

Accepted

02 November 2021

Published

10 December 2021

Volume

12 - 2021

Edited by

Kristina Kadlec, Independent Researcher, Wunstorf, Germany

Reviewed by

Gerald Larrouy-Maumus, Imperial College London, United Kingdom; John Osei Sekyere, University of Pretoria, South Africa

Updates

Copyright

© 2021 Majewski, Gutowska, Smith, Hauschild, Majewska, Hryszko, Gizycka, Kedra, Kochanowicz, Glowiński, Drewnowska, Swiecicka, Sacha, Wieczorek, Iwaniuk, Sulewska, Charkiewicz, Makarewicz, Zebrowska, Czaban, Radziwon, Niklinski and Tryniszewska.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Piotr Majewski,

This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Share on WeChat

Scan with WeChat to share this article

Article metrics